Pressroom: Media Coverage

Showing 321 - 340 of 598 news items

2012

Some Screens Miss Spread of Breast Cancer

Medical oncologist Andrew Seidman commented on a study presented at the American Society of Clinical Oncology’s Breast Cancer Symposium that found that bone scans, liver ultrasounds, and chest x-rays may not have a significant role to play in staging breast cancer.

September 11, 2012
New Cancer Drugs Are Showing Great Promise

Medical oncologist Jedd Wolchok spoke about immunotherapy and the drug ipilimumab (Yervoy), which accelerates the body’s own immune system to fight cancer.

September 11, 2012
Sloan Kettering & Hunter College in Big Med Deal

Mayor Michael Bloomberg announced that Memorial Sloan Kettering plans to build a new outpatient cancer care facility on the Upper East Side of Manhattan.

September 11, 2012
Acupuncture Relieves Pain in Largest Study of Treatment

Epidemiologist Andrew Vickers discussed a study he led that found that acupuncture is an effective treatment for chronic back and neck pain, osteoarthritis, shoulder pain, and headaches. The study received widespread media coverage and Dr. Vickers was quoted in several publications, including Reuters, TIME, HealthDay News, the New York Daily News, the Associated Press, NYTimes.com, The Atlantic, and ABCNews.com.

September 10, 2012
Young Adult Cancer Survivors May Face a Challenging Future

Director of Memorial Sloan Kettering's Adult Long-Term Follow-Up Program Kevin Oeffinger spoke about the unique needs of, and challenges for, adolescent and young adult cancer patients.

September 9, 2012
CBS 2′s Special Coverage of the 2012 Susan G. Komen Race for the Cure

Medical oncologist Heather McArthur, radiologist David Dershaw, and surgical oncologist Monica Morrow discussed the latest advances in the diagnosis and treatment for breast cancer. Clinical nurse specialist Donna Wilson also spoke about her dragon boat team made up entirely of breast cancer survivors.

September 8, 2012
Can There Be Too Much Breast-Cancer Treatment?

Medical oncologist Clifford Hudis commented on whether breast cancer is over-diagnosed.

September 4, 2012
Gene in Stem Cell Donors May Decrease Relapse Risk in Leukemia Patients

Hematologist/oncologist Katharine Hsu spoke about a study she led that found that genetic features of stem cell transplant donors may be associated with a reduced risk of relapse in acute myelogenous leukemia patients.

September 4, 2012
Androgen-Blocking Drug Wins US Approval for Prostate Cancer

Medical oncologist Howard Scher commented on the US Food and Drug Administration’s approval of enzalutamide for the treatment of men with metastatic prostate cancer. Laboratory work conducted by researcher and Human Oncology and Pathogenesis Program Chair Charles Sawyers was instrumental in the development of this novel therapy.

August 31, 2012
Robin Prepares for Medical Leave

Good Morning America co-host Robin Roberts said goodbye to her colleagues before going on medical leave to receive a bone marrow transplant at Memorial Sloan Kettering. Hematologist-oncologist and Chief of the Adult Bone Marrow Transplant Service Sergio Giralt is one of Robin’s doctors.

August 30, 2012
Breast Cancer Recurrence Risk Goes Up with Weight

Medical oncologist Clifford Hudis commented on a study that found that being moderately overweight is linked to a higher risk of breast cancer recurrence.

August 27, 2012
Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer

Medical oncologist Clifford Hudis commented on recent studies that measured aspirin’s impact on cancer risk and mortality.

August 27, 2012
The Cancer "Breakthroughs" That Cost Too Much and Do Too Little

Epidemiologist Peter Bach commented on the high costs of cancer care.

August 27, 2012
High-Tech Road Map Kills Liver Cancer

Surgeon William Jarnagin described how he used an organ positioning system to remove a cancerous liver tumor in Memorial Sloan Kettering patient Richie Rubin.

August 23, 2012
Genome Sequencing Clears Up a Cancer Medical Mystery

Cancer researcher and Human Oncology and Pathogenesis Program member David Solit spoke about a study he led that sequenced the entire genome of a patient whose cancer disappeared when she took an experimental drug that didn’t help others.

August 23, 2012
Child Cancer Patients at Greater Risk of Diabetes, Study Shows

Directors of Memorial Sloan Kettering’s long-term follow-up programs Kevin Oeffinger and Charles Sklar authored a commentary on a study that found that cancer patients who underwent radiation therapy as children are at greater risk of developing diabetes later in life.

August 22, 2012
Watson Turns Medic: Supercomputer to Diagnose Disease

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on Memorial Sloan Kettering’s collaboration with IBM to develop a decision-support tool based upon the IBM Watson system.

August 22, 2012
Jewish Men in Middle of PSA Controversy

Prostate cancer surgeon James Eastham spoke about screening men for prostate cancer. BRCA gene mutations, which are ten times more common in Ashkenazi Jews, can increase the risk for breast, ovarian, and prostate cancers.

August 17, 2012
Experimental Pill Adds Months to Lives of Prostate Cancer Patients

Medical oncologist Howard Scher discussed a study he led that found that a novel drug extended the lives of men with advanced prostate cancer.

August 15, 2012
Amgen, Citing Weak Results, Halts Study of a Cancer Drug

Medical oncologist Leonard Saltz commented on a late-stage clinical trial of an experimental drug for pancreatic cancer that was halted after an outside monitoring panel concluded that the drug was unlikely to improve the survival of patients with an advanced form of the disease.

August 10, 2012